Citadel Advisors
BLUE

Citadel Advisors’s bluebird bio BLUE Stock Holding History

Citadel Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,715
Closed -$42.5K – 12622
2025
Q1 		$42.5K Buy
8,715
+1,695
+24% +$10.2K ﹤0.01% 12473
2024
Q4 		$58.5K Sell
7,020
-6,220
-47% -$54.4K ﹤0.01% 12212
2024
Q3 		$138K Buy
13,240
+1,740
+15% +$28.9K ﹤0.01% 10679
2024
Q2 		$226K Sell
11,500
-4,465
-28% -$89.4K ﹤0.01% 9667
2024
Q1 		$409K Sell
15,965
-12,460
-44% -$319K ﹤0.01% 8822
2023
Q4 		$785K Buy
28,425
+14,565
+105% +$888K ﹤0.01% 7175
2023
Q3 		$843K Buy
13,860
+2,340
+20% +$164K ﹤0.01% 6942
2023
Q2 		$758K Buy
11,520
+1,565
+16% +$114K ﹤0.01% 7038
2023
Q1 		$633K Buy
9,955
+4,090
+70% +$467K ﹤0.01% 7818
2022
Q4 		$812K Sell
5,865
-3,925
-40% -$553K ﹤0.01% 7225
2022
Q3 		$1.24M Sell
9,790
-3,635
-27% -$411K ﹤0.01% 6528
2022
Q2 		$1.11M Buy
13,425
+10,220
+319% +$793K ﹤0.01% 6781
2022
Q1 		$311K Sell
3,205
-2,280
-42% -$301K ﹤0.01% 10510
2021
Q4 		$1.1M Buy
5,485
+868
+19% +$205K ﹤0.01% 7721
2021
Q3 		$1.14M Sell
4,617
-1,559
-25% -$446K ﹤0.01% 7810
2021
Q2 		$2.56M Sell
6,176
-2,131
-26% -$844K ﹤0.01% 5976
2021
Q1 		$3.24M Buy
8,307
+950
+13% +$468K ﹤0.01% 5250
2020
Q4 		$4.12M Sell
7,357
-131
-2% -$83K ﹤0.01% 4000
2020
Q3 		$5.23M Buy
7,488
+1,088
+17% +$849K ﹤0.01% 3089
2020
Q2 		$5.06M Buy
6,400
+579
+10% +$437K ﹤0.01% 3068
2020
Q1 		$3.46M Sell
5,821
-625
-10% -$609K ﹤0.01% 3237
2019
Q4 		$7.33M Buy
6,446
+1,413
+28% +$1.54M ﹤0.01% 2580
2019
Q3 		$5.99M Sell
5,033
-2,764
-35% -$4.22M ﹤0.01% 2860
2019
Q2 		$12.8M Buy
7,797
+3,350
+75% +$5.8M 0.01% 1881
2019
Q1 		$9.06M Sell
4,447
-2,694
-38% -$4.74M ﹤0.01% 2201
2018
Q4 		$9.18M Sell
7,141
-54
-0.8% -$82.8K 0.01% 1999
2018
Q3 		$13.6M Sell
7,195
-3,320
-32% -$6.86M 0.01% 1762
2018
Q2 		$21.4M Buy
10,515
+873
+9% +$1.99M 0.01% 1257
2018
Q1 		$21.3M Buy
9,642
+2,756
+40% +$7.01M 0.01% 1068
2017
Q4 		$15.9M Buy
6,886
+1,111
+19% +$2.26M 0.01% 1326
2017
Q3 		$10.3M Buy
5,775
+1,884
+48% +$2.63M 0.01% 1575
2017
Q2 		$5.29M Buy
3,891
+1,953
+101% +$2.36M ﹤0.01% 2064
2017
Q1 		$2.28M Buy
1,938
+1,212
+167% +$1.24M ﹤0.01% 2926
2016
Q4 		$580K Sell
726
-1,212
-63% -$962K ﹤0.01% 4675
2016
Q3 		$1.7M Sell
1,938
-231
-11% -$167K ﹤0.01% 3162
2016
Q2 		$1.22M Sell
2,169
-1,382
-39% -$783K ﹤0.01% 3325
2016
Q1 		$1.96M Buy
3,551
+749
+27% +$460K ﹤0.01% 2666
2015
Q4 		$2.33M Sell
2,802
-255
-8% -$255K ﹤0.01% 2584
2015
Q3 		$3.39M Sell
3,057
-54
-2% -$98.5K ﹤0.01% 2329
2015
Q2 		$6.79M Buy
3,111
+880
+39% +$1.79M 0.01% 1766
2015
Q1 		$3.49M Sell
2,231
-347
-13% -$458K ﹤0.01% 2419
2014
Q4 		$3.06M Buy
2,578
+1,551
+151% +$1.04M ﹤0.01% 2461
2014
Q3 		$477K Buy
1,027
+348
+51% +$161K ﹤0.01% 4679
2014
Q2 		$339K Buy
+679
New +$218K ﹤0.01% 4886

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's BLUE Position: Q3 2024 in Review

Citadel Advisors sold out of bluebird bio (BLUE) in Q3 2024, closing a stake of 10,390 shares — an estimated $173K sold.

Citadel Advisors first reported a position in BLUE in Q2 2013 and held it in 39 quarters. The position peaked at $69.6M in Q4 2019. 140 funds tracked by Wall St. Rank hold BLUE as of Q3 2024.

  • Citadel Advisors reported no remaining bluebird bio position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 10,390 bluebird bio shares in Q3 2024, an estimated $173K.
  • Citadel Advisors first reported a position in bluebird bio in Q2 2013 and held it in 39 quarters.
  • Citadel Advisors's bluebird bio position peaked at $69.6M in Q4 2019.
  • 140 funds tracked by Wall St. Rank held bluebird bio as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.